Stammdaten
Halozyme Therapeutics, Inc. ist ein Biopharma-Technologieplattformunternehmen in den Vereinigten Staaten, der Schweiz, Irland, Belgien, Japan und international. Die Produkte des Unternehmens basieren auf der ENHANZE-Arzneimittelabgabetechnologie, einem patentierten rekombinanten menschlichen Hyaluronidase-Enzym (rHuPH20), das die subkutane Verabreichung biologischer Injektionsmittel wie monoklonaler Antikörper und anderer therapeutischer Moleküle sowie kleinmolekularer Substanzen und Flüssigkeiten ermöglicht. Das Flaggschiff-Produkt ist Hylenex recombinant, eine Formulierung von rHuPH20 zur Erleichterung der subkutanen Flüssigkeitsverabreichung für die Hydratation, um die Ausbreitung und Absorption anderer injizierter Arzneimittel in der subkutanen Urographie zu verbessern und die Resorption von radioopaken Mitteln zu verbessern. Das Unternehmen entwickelt auch Perjeta; RITUXAN HYCELA und MabThera SC zur Behandlung von Non-Hodgkin-Lymphom und chronisch lymphatischer Leukämie (CLL); RITUXAN SC für Patienten mit CLL; und HYQVIA zur Behandlung von Immunmangelstörungen. Darüber hinaus entwickelt es Tecentriq für Nicht-kleinzelliges Lungenkarzinom; OCREVUS für Multiple Sklerose; DARZALEX zur Behandlung von Patienten mit Amyloidose, schwelender Myelom und Multiplem Myelom; Nivolumab zur Behandlung solider Tumoren; ARGX-113, einen menschlichen neonatalen Fc-Rezeptor; ARGX-117 zur Behandlung von Autoimmunerkrankungen; und BMS-986179, einen Anti-CD-73-Antikörper. Das Unternehmen kooperiert mit F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; und ViiV Healthcare Limited an klein- und großmolekularen Zielen zur Behandlung und Prävention von HIV. Halozyme Therapeutics, Inc. wurde 1998 gegründet und hat seinen Sitz in San Diego, Kalifornien. KI
Unternehmen & Branche
| Name | HALOZYME THERAPEUTICS, INC. |
|---|---|
| Ticker | HALO |
| CIK | 0001159036 |
| Börse | Nasdaq |
| Sektor | Gesundheit |
| Industrie | Biotechnologie (Forschung) |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 40637H109 |
|---|---|
| ISIN | US40637H1095 |
| Typ | Common Stock |
| Marktkapitalisierung | 9,83 Mrd. USD |
| KGV (P/E) | 32,60 |
| Beta | 0,84 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 12390 EL CAMINO REAL, 92130 SAN DIEGO, CA |
| Telefon | (858) 794-8889 |
| EIN (IRS) | 88-0488686 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
| Frühere Namen | HALOZYME THERAPEUTICS INC (bis 2019) GLOBAL YACHT SERVICES INC (bis 2004) |
Bewertung
| KBV (P/B) | 201,35 vs. 28,07 (2021) ▲ |
|---|---|
| KUV (P/S) | 7,04 vs. 12,47 (2021) ▼ |
| EV/EBITDA | 24,6 vs. 22,5 (2021) ▲ |
| FCF-Rendite | 6,6 % vs. 5,4 % (2021) ▲ |
| Buyback-Rendite | 3,5 % vs. 6,3 % (2021) ▼ |
Qualität & Bilanz
| Bruttomarge | 83,6 % vs. 81,6 % (2021) ▲ |
|---|---|
| Operative Marge | 33,6 % vs. 62,2 % (2021) ▼ |
| Nettomarge | 22,7 % vs. 90,8 % (2021) ▼ |
| ROIC | 14,5 % vs. 37,5 % (2021) ▼ |
| Nettoverschuldung/EBITDA | 4,2 vs. 2,7 (2021) ▲ |
| Zinsdeckungsgrad | 25,9 vs. 36,7 (2021) ▼ |
| Forderungslaufzeit (DSO) | 111 T vs. 75 T (2021) ▲ |
| Lagerreichweite (DIO) | 282 T vs. 242 T (2021) ▲ |
| Verbindlichkeitslaufzeit (DPO) | 33 T vs. 7 T (2021) ▲ |
| Cash-Conversion-Cycle (CCC) | 360 T vs. 310 T (2021) ▲ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 28,07 | 45,29 | 55,91 | 16,18 | 162,39 | 44,75 | |
| KUV (P/S) | 12,47 | 11,65 | 5,65 | 5,80 | 5,68 | 6,52 | |
| EV/EBITDA | 22,5 | 32,7 | 17,4 | 13,0 | 20,7 | 22,2 | |
| FCF-Rendite | 5,4 % | 3,1 % | 8,0 % | 8,0 % | 8,1 % | 6,8 % | |
| Buyback-Rendite | 6,3 % | 2,6 % | 8,6 % | 4,2 % | 4,3 % | – | |
| Qualität & Bilanz | |||||||
| Bruttomarge | 81,6 % | 78,9 % | 76,8 % | 84,3 % | 83,6 % | 82,8 % | |
| Operative Marge | 62,2 % | 40,5 % | 40,7 % | 54,3 % | 33,6 % | 33,9 % | |
| Nettomarge | 90,8 % | 30,6 % | 34,0 % | 43,7 % | 22,7 % | 23,1 % | |
| ROIC | 37,5 % | 12,1 % | 17,8 % | 23,8 % | 14,5 % | 14,8 % | |
| Nettoverschuldung/EBITDA | 2,7 | 4,6 | 4,0 | 2,5 | 4,2 | 3,5 | |
| Zinsdeckungsgrad | 36,7 | 15,8 | 18,0 | 30,5 | 25,9 | 26,8 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
HALO
HALOZYME THERAPEUTICS, INC.
Effektiv
Neutral
Handelsvolumen
Hoch
Insider
0,0
Keine Insider-Käufe
Institutionell
52,6
101 neu, 249 erhöht, -576048K $ netto
Aktivist
17,8
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 73.72 | +13.0 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 69.67 | +19.5 % vs SMA200 | |
| SMA-Cross | Bullisch | 10 % | GOLDEN | vor 17 Tagen @ 80.78 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 78.71 | EMA50: 74.97 | |
| MACD-Histogramm | Bullisch | 10 % | 0.330 | Bullisch | |
| RSI(14) | Neutral | 10 % | 68.2 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 89.0 | Überkauft | |
| ADX(14)+DI | Bullisch | 10 % | 30.8 | +DI: 31.3 / −DI: 10.7 | |
| Z-Score(60) | Bärisch | 5 % | 2.00 | Extrem überkauft | |
| 52W-Position | Bullisch | 5 % | 99.3 % | Hoch 83.45 / Tief 59.02 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 92.8 % | Upper 84.00 / Mid 79.04 / Lower 74.08 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.2767 | R²=0.81 / annualisiert +96.1 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-07-08 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.035 | 80,19 | -82.993,55 | -20,5% | |
| 2026-07-08 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -888 | 79,28 | -70.397,09 | -17,3% | |
| 2026-07-01 | Connaughton Bernadette | Director | Open Market Sale | -1.000 | 76,40 | -76.395,00 | -18,8% | |
| 2026-07-01 | Connaughton Bernadette | Director | Open Market Sale | -625 | 77,21 | -48.255,63 | -11,9% | |
| 2026-06-29 | Krishnan Mahesh | Director | Open Market Sale | -7.304 | 75,00 | -547.800,00 | -135,0% | |
| 2026-06-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.500 | 67,68 | -101.512,50 | -25,0% | |
| 2026-06-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.100 | 69,69 | -425.121,20 | -104,8% | |
| 2026-06-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.000 | 68,74 | -137.472,00 | -33,9% | |
| 2026-06-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -400 | 66,37 | -26.547,20 | -6,5% | |
| 2026-06-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -16.600 | 66,31 | -1.100.812,40 | -271,3% | |
| 2026-06-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.400 | 66,75 | -226.933,00 | -55,9% | |
| 2026-06-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.610 | 66,39 | -106.884,68 | -26,3% | |
| 2026-06-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -12.989 | 67,41 | -875.588,49 | -215,8% | |
| 2026-06-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.401 | 68,35 | -369.136,75 | -91,0% | |
| 2026-06-01 | Connaughton Bernadette | Director | Open Market Sale | -1.625 | 66,21 | -107.591,25 | -26,5% | |
| 2026-05-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.100 | 68,10 | -143.014,20 | -35,2% | |
| 2026-05-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.950 | 69,79 | -275.658,65 | -67,9% | |
| 2026-05-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.350 | 68,88 | -230.748,00 | -56,9% | |
| 2026-05-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -600 | 70,81 | -42.487,20 | -10,5% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -100 | 67,85 | -6.785,00 | -1,7% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.802 | 71,37 | -699.568,74 | -172,4% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.900 | 72,15 | -425.673,20 | -104,9% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.800 | 73,12 | -204.738,80 | -50,5% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.398 | 70,29 | -98.261,23 | -24,2% | |
| 2026-05-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.725 | 64,63 | -628.536,48 | -154,9% | |
| 2026-05-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.700 | 66,33 | -444.390,90 | -109,5% | |
| 2026-05-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.575 | 65,46 | -234.012,35 | -57,7% | |
| 2026-05-01 | Connaughton Bernadette | Director | Open Market Sale | -1.625 | 63,48 | -103.155,00 | -25,4% | |
| 2026-04-06 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.100 | 64,02 | -262.461,50 | -64,7% | |
| 2026-04-06 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.900 | 63,14 | -372.520,10 | -91,8% | |
| 2026-04-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -15.800 | 64,06 | -1.012.195,40 | -249,4% | |
| 2026-04-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.200 | 64,89 | -272.525,40 | -67,2% | |
| 2026-04-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.000 | 65,71 | -65.714,00 | -16,2% | |
| 2026-04-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -19.000 | 65,36 | -1.241.802,00 | -306,0% | |
| 2026-03-10 | Caudill Cortney | Officer, SVP, CHIEF OPERATING OFFICER | Open Market Sale | -8.857 | 67,64 | -599.087,48 | -147,6% | |
| 2026-03-09 | Caudill Cortney | Officer, SVP, CHIEF OPERATING OFFICER | Open Market Sale | -17.900 | 67,75 | -1.212.742,90 | -298,9% | |
| 2026-03-09 | Caudill Cortney | Officer, SVP, CHIEF OPERATING OFFICER | Open Market Sale | -2.100 | 68,25 | -143.329,20 | -35,3% | |
| 2026-03-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -7.329 | 69,94 | -512.619,58 | -126,3% | |
| 2026-03-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.671 | 70,95 | -189.494,10 | -46,7% | |
| 2026-03-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -13.481 | 68,85 | -928.166,85 | -228,7% | |
| 2026-03-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.519 | 69,33 | -451.981,83 | -111,4% | |
| 2026-03-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.100 | 69,20 | -283.707,70 | -69,9% | |
| 2026-03-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -15.322 | 69,80 | -1.069.460,28 | -263,6% | |
| 2026-03-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -578 | 70,46 | -40.726,46 | -10,0% | |
| 2026-02-05 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.376 | 78,38 | -421.365,50 | -103,8% | |
| 2026-02-05 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.624 | 78,94 | -365.000,06 | -89,9% | |
| 2026-02-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -10.100 | 77,54 | -783.154,00 | -193,0% | |
| 2026-02-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.900 | 76,94 | -761.666,40 | -187,7% | |
| 2026-02-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.551 | 74,88 | -191.016,33 | -47,1% | |
| 2026-02-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -7.790 | 76,73 | -597.757,86 | -147,3% | |
| 2026-02-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.659 | 75,94 | -733.543,10 | -180,8% | |
| 2026-01-05 | Connaughton Bernadette | Director | Open Market Sale | -2.000 | 70,25 | -140.500,00 | -34,6% | |
| 2025-12-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -261 | 71,60 | -18.687,60 | -4,6% | |
| 2025-12-01 | Connaughton Bernadette | Director | Open Market Sale | -829 | 71,60 | -59.356,40 | -14,6% | |
| 2025-12-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -10.406 | 68,51 | -712.935,87 | -175,7% | |
| 2025-12-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.402 | 69,44 | -375.120,28 | -92,4% | |
| 2025-12-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -500 | 70,36 | -35.181,00 | -8,7% | |
| 2025-11-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -12.718 | 70,22 | -893.032,52 | -220,1% | |
| 2025-11-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -498 | 71,67 | -35.690,17 | -8,8% | |
| 2025-11-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.784 | 71,09 | -482.267,78 | -118,8% | |
| 2025-11-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -11.500 | 69,73 | -801.906,50 | -197,6% | |
| 2025-11-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.000 | 68,80 | -275.180,00 | -67,8% | |
| 2025-11-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.500 | 67,89 | -305.514,00 | -75,3% | |
| 2025-11-10 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -100 | 69,30 | -6.930,00 | -1,7% | |
| 2025-11-10 | Connaughton Bernadette | Director | Open Market Sale | -2.000 | 68,48 | -136.960,00 | -33,8% | |
| 2025-11-10 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -19.900 | 68,71 | -1.367.408,60 | -337,0% | |
| 2025-11-01 | Caudill Cortney | Officer, SVP, CHIEF OPERATING OFFICER | Open Market Sale | -4.263 | 65,19 | -277.904,97 | -68,5% | |
| 2025-10-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.334 | 69,83 | -162.983,22 | -40,2% | |
| 2025-10-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -14.235 | 68,47 | -974.698,92 | -240,2% | |
| 2025-10-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.707 | 70,58 | -191.065,47 | -47,1% | |
| 2025-10-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -724 | 71,67 | -51.890,53 | -12,8% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -100 | 74,67 | -7.466,50 | -1,8% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -10.200 | 71,28 | -727.035,60 | -179,2% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.600 | 70,51 | -465.359,40 | -114,7% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.400 | 72,07 | -172.956,00 | -42,6% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -700 | 73,24 | -51.265,20 | -12,6% | |
| 2025-10-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -11.705 | 75,11 | -879.150,85 | -216,7% | |
| 2025-10-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -8.295 | 75,69 | -627.873,44 | -154,7% | |
| 2025-10-01 | Connaughton Bernadette | Director | Open Market Sale | -1.500 | 75,09 | -112.629,00 | -27,8% | |
| 2025-10-01 | Connaughton Bernadette | Director | Open Market Sale | -500 | 75,70 | -37.852,00 | -9,3% | |
| 2025-09-22 | LaBrosse Nicole | Officer, SVP, CHIEF FINANCIAL OFFICER | Open Market Sale | -314 | 78,67 | -24.701,44 | -6,1% | |
| 2025-09-22 | LaBrosse Nicole | Officer, SVP, CHIEF FINANCIAL OFFICER | Open Market Sale | -1.913 | 77,83 | -148.883,05 | -36,7% | |
| 2025-09-10 | LaBrosse Nicole | Officer, SVP, CHIEF FINANCIAL OFFICER | Open Market Sale | -13.240 | 75,93 | -1.005.299,96 | -247,7% | |
| 2025-09-10 | LaBrosse Nicole | Officer, SVP, CHIEF FINANCIAL OFFICER | Open Market Sale | -6.760 | 75,29 | -508.967,16 | -125,4% | |
| 2025-09-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -7.800 | 74,33 | -579.750,60 | -142,9% | |
| 2025-09-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.900 | 73,54 | -728.006,40 | -179,4% | |
| 2025-09-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.300 | 75,22 | -173.015,20 | -42,6% | |
| 2025-09-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -10.500 | 74,63 | -783.636,00 | -193,1% | |
| 2025-09-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.500 | 74,22 | -705.090,00 | -173,8% | |
| 2025-09-02 | Connaughton Bernadette | Director | Open Market Sale | -923 | 74,11 | -68.404,45 | -16,9% | |
| 2025-09-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -16.288 | 73,70 | -1.200.393,02 | -295,8% | |
| 2025-09-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.412 | 74,15 | -252.989,56 | -62,3% | |
| 2025-09-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -300 | 72,49 | -21.745,50 | -5,4% | |
| 2025-09-02 | Connaughton Bernadette | Director | Open Market Sale | -2.977 | 73,62 | -219.160,79 | -54,0% | |
| 2025-09-02 | Connaughton Bernadette | Director | Open Market Sale | -100 | 71,71 | -7.171,00 | -1,8% | |
| 2025-08-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -14.948 | 64,15 | -958.839,46 | -236,3% | |
| 2025-08-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.052 | 64,83 | -327.511,06 | -80,7% | |
| 2025-08-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.958 | 64,00 | -445.318,96 | -109,7% | |
| 2025-08-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -13.042 | 63,24 | -824.802,16 | -203,3% | |
| 2025-08-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -18.717 | 63,01 | -1.179.320,74 | -290,6% | |
| 2025-08-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.283 | 63,60 | -81.596,23 | -20,1% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 3394 von typischerweise 8409 Fonds (40 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 20.890.053 | 0 | 20.890.053 | 867.076.530 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.271.218 | 0 | 5.271.218 | 340.678.819 | Neu | +100,0% | |
| STATE STREET CORP | 13.975.854 | 0 | 13.975.854 | 330.786.146 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 5.026.109 | 0 | 5.026.109 | 190.977.806 | Neu | +100,0% | |
| Boston Partners | 2.683.683 | 0 | 2.683.683 | 173.432.991 | Neu | +100,0% | |
| MORGAN STANLEY | 4.977.309 | 0 | 4.977.309 | 168.688.554 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.525.975 | 0 | 2.525.975 | 163.253.764 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.505.786 | 0 | 2.505.786 | 161.982.673 | Neu | +100,0% | |
| SNYDER CAPITAL MANAGEMENT L P | 2.323.077 | 0 | 2.323.077 | 150.140.467 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 2.079.827 | 0 | 2.079.827 | 134.398.148 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.918.149 | 0 | 1.918.149 | 123.969.970 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 1.899.408 | 0 | 1.899.408 | 122.758.740 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 1.736.501 | 0 | 1.736.501 | 116.866.517 | Neu | +100,0% | |
| Stephens Investment Management Group LLC | 1.392.819 | 1.218.668 | 174.151 | 109.015.943 | Aufgestockt | +14,3% | |
| WELLS FARGO & COMPANY/MN | 9.092.737 | 0 | 9.092.737 | 108.634.839 | Neu | +100,0% | |
| ROYAL LONDON ASSET MANAGEMENT LTD | 1.610.553 | 0 | 1.610.553 | 104.090.040 | Neu | +100,0% | |
| JUPITER ASSET MANAGEMENT LTD | 1.608.256 | 0 | 1.608.256 | 103.941.586 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 1.584.961 | 0 | 1.584.961 | 102.436.029 | Neu | +100,0% | |
| CONGRESS ASSET MANAGEMENT CO | 1.229.106 | 1.280.592 | -51.486 | 96.202.127 | Reduziert | -4,0% | |
| FIRST TRUST ADVISORS LP | 1.482.340 | 0 | 1.482.340 | 95.803.603 | Neu | +100,0% | |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.465.283 | 0 | 1.465.283 | 94.701.251 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 9.528.039 | 0 | 9.528.039 | 85.510.936 | Neu | +100,0% | |
| Boston Trust Walden Corp | 1.083.062 | 679.563 | 403.499 | 84.771.263 | Aufgestockt | +59,4% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.289.533 | 0 | 1.289.533 | 83.342.518 | Neu | +100,0% | |
| Janus Henderson Group Ltd. | 1.233.658 | 0 | 1.233.658 | 79.741.989 | Neu | +100,0% | |
| Assenagon Asset Management S.A. | 997.643 | 21.322 | 976.321 | 78.085.518 | Aufgestockt | +4578,9% | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.186.951 | 0 | 1.186.951 | 76.713.000 | Neu | +100,0% | |
| BANK OF MONTREAL /CAN/ | 7.689.597 | 0 | 7.689.597 | 76.612.235 | Neu | +100,0% | |
| TD ASSET MANAGEMENT INC | 1.168.666 | 0 | 1.168.666 | 75.530.884 | Neu | +100,0% | |
| Epoch Investment Partners, Inc. | 1.138.377 | 0 | 1.138.377 | 73.573.306 | Neu | +100,0% | |
| FEDERATED HERMES, INC. | 1.123.266 | 0 | 1.123.266 | 72.596.682 | Neu | +100,0% | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 1.121.200 | 0 | 1.121.200 | 72.463.156 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1.111.231 | 0 | 1.111.231 | 71.818.860 | Neu | +100,0% | |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 55.026.000 | 0 | 55.026.000 | 71.004.180 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 44.828.851 | 0 | 44.828.851 | 70.746.121 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 54.851.000 | 0 | 54.851.000 | 68.677.931 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 29.394.284 | 0 | 29.394.284 | 67.606.022 | Neu | +100,0% | |
| Mizuho Markets Cayman LP | 834.500 | 0 | 834.500 | 65.316.315 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 1.016.429 | 0 | 1.016.429 | 64.817.665 | Neu | +100,0% | |
| UBS Group AG | 979.333 | 0 | 979.333 | 59.140.076 | Neu | +100,0% | |
| Capital World Investors | 3.026.902 | 0 | 3.026.902 | 59.113.736 | Neu | +100,0% | |
| LMR Partners LLP | 45.000.000 | 0 | 45.000.000 | 57.712.500 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 1.004.407 | 0 | 1.004.407 | 57.441.107 | Neu | +100,0% | |
| Nuveen, LLC | 12.932.124 | 0 | 12.932.124 | 51.064.011 | Neu | +100,0% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 789.429 | 0 | 789.429 | 51.020.796 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1.630.140 | 0 | 1.630.140 | 48.345.683 | Neu | +100,0% | |
| Gotham Asset Management, LLC | 746.841 | 0 | 746.841 | 48.268.334 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 731.811 | 0 | 731.811 | 47.296.945 | Neu | +100,0% | |
| Alberta Investment Management Corp | 35.000.000 | 0 | 35.000.000 | 45.050.600 | Neu | +100,0% | |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 689.915 | 0 | 689.915 | 44.589.205 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 3394 von typischerweise 8409 Fonds (40 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| Stephens Investment Management Group LLC | 1.392.819 | 1.218.668 | +14,3% | 109.015.943 | 13,41 | 0 % | 17 Q |
| CONGRESS ASSET MANAGEMENT CO | 1.229.106 | 1.280.592 | -4,0% | 96.202.127 | 11,83 | 89 % | 13 Q |
| Boston Trust Walden Corp | 1.083.062 | 679.563 | +59,4% | 84.771.263 | 10,43 | 94 % | 9 Q |
| Assenagon Asset Management S.A. | 997.643 | 21.322 | +4578,9% | 78.085.518 | 9,60 | 100 % | 13 Q |
| Mizuho Markets Cayman LP | 834.500 | 0 | +100,0% | 65.316.315 | 8,03 | 100 % | 2 Q |
| Arbejdsmarkedets Tillaegspension | 415.300 | 408.391 | +1,7% | 32.505.531 | 4,00 | 100 % | 3 Q |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 403.824 | 0 | +100,0% | 31.607.304 | 3,89 | 72 % | 1 Q |
| MIZUHO MARKETS AMERICAS LLC | 393.081 | 1.323.544 | -70,3% | 30.766.450 | 3,78 | 100 % | 16 Q |
| Retirement Systems of Alabama | 352.454 | 373.943 | -5,7% | 27.586.575 | 3,39 | 100 % | 17 Q |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 14.000.000 | 14.000.000 | 0,0% | 20.403.060 | 2,51 | 100 % | 12 Q |
| Swedbank AB | 202.412 | 160.712 | +25,9% | 15.842.788 | 1,95 | 100 % | 16 Q |
| ASSETMARK, INC | 174.334 | 166.617 | +4,6% | 13.645.122 | 1,68 | 100 % | 17 Q |
| OFI INVEST ASSET MANAGEMENT | 6.800.000 | 6.800.000 | 0,0% | 8.736.667 | 1,07 | 100 % | 11 Q |
| Artemis Investment Management LLP | 108.284 | 110.860 | -2,3% | 8.475.389 | 1,04 | 100 % | 6 Q |
| Koa Wealth Management, LLC | 94.333 | 93.822 | +0,5% | 7.383.444 | 0,91 | 0 % | 11 Q |
| LBP AM SA | 5.000.000 | 0 | +100,0% | 7.344.739 | 0,90 | 100 % | 5 Q |
| MACKAY SHIELDS LLC | 5.407.000 | 5.416.000 | -0,2% | 6.007.958 | 0,74 | 1 % | 17 Q |
| BERNZOTT CAPITAL ADVISORS | 76.376 | 68.277 | +11,9% | 5.977.950 | 0,74 | 100 % | 16 Q |
| Union Bancaire Privee, UBP SA | 4.605.000 | 4.190.000 | +9,9% | 5.769.036 | 0,71 | 0 % | 7 Q |
| RATIONAL ADVISORS, INC. | 5.110.000 | 2.970.000 | +72,1% | 5.677.713 | 0,70 | 0 % | 3 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 234 | 52,4 | 816 |
| 31.03.2026 | ✓ | 662 | 804,9 | 8.754 |
| 31.12.2025 | ✓ | 646 | 1.138,9 | 9.546 |
| 30.09.2025 | ✓ | 650 | 1.691,0 | 10.625 |
| 30.06.2025 | ✓ | 600 | 1.554,3 | 7.344 |
| 31.03.2025 | ✓ | 584 | 1.747,8 | 9.772 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| STEELHEAD PARTNERS LLC | 19.053.000 | 19.828.914 |
| TPG GP A, LLC | 10.000.000 | 10.368.750 |
| Lisanti Capital Growth, LLC | 54.445 | 3.518.780 |
| Thrive Capital Management, LLC | 51.632 | 3.336.976 |
| Peak Retirement Planning, Inc. | 46.617 | 3.012.865 |
| Boussard & Gavaudan Investment Management LLP | 2.100 | 2.669.515 |
| NORDEA INVESTMENT MANAGEMENT AB | 38.991 | 2.470.469 |
| JOHNSON INVESTMENT COUNSEL INC | 36.787 | 2.377.544 |
| Sidoxia Capital Management, LLC | 34.758 | 2.246.410 |
| SEB Asset Management AB | 34.700 | 2.242.658 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 55.026.000 | 15.400.000 | +38.9 % | 71.004.180 |
| BALYASNY ASSET MANAGEMENT L.P. | 23.985.000 | 9.200.000 | +62.2 % | 29.419.490 |
| MILLENNIUM MANAGEMENT LLC | 29.394.284 | 8.007.336 | +37.4 % | 67.606.022 |
| Point72 Asset Management, L.P. | 54.851.000 | 6.500.000 | +13.4 % | 68.677.931 |
| ADVENT CAPITAL MANAGEMENT /DE/ | 10.699.000 | 6.201.000 | +137.9 % | 13.046.706 |
| VOYA INVESTMENT MANAGEMENT LLC | 6.036.818 | 5.999.950 | +16274.1 % | 10.071.547 |
| CITIGROUP INC | 10.266.341 | 4.756.238 | +86.3 % | 18.297.823 |
| LMR Partners LLP | 45.000.000 | 4.492.000 | +11.1 % | 57.712.500 |
| Boston Partners | 2.683.683 | 2.196.614 | +451.0 % | 173.432.991 |
| BlackRock, Inc. | 20.890.053 | 1.986.196 | +10.5 % | 867.076.530 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 44.738.051 | -21.110.949 | -32.1 % | 64.877.717 |
| MORGAN STANLEY | 4.977.309 | -7.455.990 | -60.0 % | 168.688.554 |
| Jefferies Financial Group Inc. | 32.000 | -3.499.925 | -99.1 % | 2.068.160 |
| WELLS FARGO & COMPANY/MN | 9.092.737 | -3.454.780 | -27.5 % | 108.634.839 |
| Walleye Capital LLC | 53.364 | -2.991.304 | -98.2 % | 3.448.915 |
| TORONTO DOMINION BANK | 7.355 | -2.492.649 | -99.7 % | 475.350 |
| LAZARD ASSET MANAGEMENT LLC | 16.254.011 | -2.168.232 | -11.8 % | 6.864.657 |
| Warberg Asset Management LLC | 6.000.000 | -2.000.000 | -25.0 % | 7.717.481 |
| BANK OF AMERICA CORP /DE/ | 5.026.109 | -1.891.723 | -27.3 % | 190.977.806 |
| Man Group plc | 2.371.488 | -1.330.124 | -35.9 % | 11.564.844 |
Zusätzlich aktuell von 250 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,21 % | 6.173.547 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,04 pp | |
| 17.07.2025 | BlackRock, Inc. | Passiv (13G/A) | 10,20 % | 12.612.300 | -2,90 pp | |
| 13.05.2025 | STATE STREET CORPORATION | Passiv (13G) | 4,90 % | 6.053.007 | -0,30 pp | |
| 28.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 13,10 % | 16.144.164 | Neu | |
| 12.11.2024 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 2,50 % | 3.133.412 | -2,60 pp | |
| 17.10.2024 | STATE STREET CORPORATION | Passiv (13G) | 5,20 % | 6.635.827 | Neu | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 10,04 % | 13.259.514 | -0,23 pp | |
| 12.02.2024 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 5,10 % | 6.689.058 | Neu | |
| 01.02.2024 | Invesco Ltd. | Passiv (13G/A) | 2,10 % | 2.816.427 | -3,10 pp | |
| 23.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 14,10 % | 18.629.818 | -0,10 pp | |
| 09.06.2023 | The Vanguard Group | Passiv (13G/A) | 10,27 % | 13.528.630 | +0,43 pp | |
| 10.02.2023 | . BlackRock, Inc. | Passiv (13G/A) | 14,20 % | 19.196.061 | +0,60 pp | |
| 10.02.2023 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 5,30 % | 7.140.953 | -1,50 pp | |
| 10.02.2023 | Invesco Ltd. | Passiv (13G) | 5,20 % | 7.036.951 | Neu | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 9,84 % | 13.303.847 | -0,18 pp | |
| 26.01.2023 | . BlackRock, Inc. | Passiv (13G/A) | 13,60 % | 18.214.071 | 0,00 pp | |
| 20.01.2023 | . BlackRock, Inc. | Passiv (13G) | 13,60 % | 18.214.071 | -0,20 pp | |
| 12.12.2022 | The Vanguard Group | Passiv (13G/A) | 10,02 % | 13.542.589 | +0,43 pp | |
| 10.02.2022 | The Vanguard Group | Passiv (13G/A) | 9,59 % | 13.495.913 | -0,14 pp | |
| 04.02.2022 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 6,80 % | 9.505.768 | -0,80 pp | |
| 28.01.2022 | . BlackRock, Inc. | Passiv (13G/A) | 13,80 % | 19.439.863 | +0,10 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 09.03.2026 | Gilbert Cisneros | – | House | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | 150.049.000 $ | 1,22 $ | 2.672.719.000 $ | 219.636.000 $ |
| 2025-12-31 | 10-K | – | 316.889.000 $ | 2,56 $ | 2.525.323.000 $ | 48.814.000 $ |
| 2025-09-30 | 10-Q | – | 175.225.000 $ | 1,43 $ | 2.221.232.000 $ | 503.915.000 $ |
| 2025-06-30 | 10-Q | – | 165.160.000 $ | 1,33 $ | 2.053.899.000 $ | 332.748.000 $ |
| 2025-03-31 | 10-Q | – | 118.095.000 $ | 0,93 $ | 2.196.532.000 $ | 482.270.000 $ |
| 2024-12-31 | 10-K | – | 444.091.000 $ | 3,43 $ | 2.063.477.000 $ | 363.821.000 $ |
| 2024-09-30 | 10-Q | – | 137.011.000 $ | 1,05 $ | 2.118.030.000 $ | 452.703.000 $ |
| 2024-06-30 | 10-Q | – | 93.245.000 $ | 0,72 $ | 1.969.453.000 $ | 289.424.000 $ |
| 2024-03-31 | 10-Q | – | 76.823.000 $ | 0,60 $ | 1.841.527.000 $ | 177.808.000 $ |
| 2023-12-31 | 10-K | – | 281.594.000 $ | 2,10 $ | 1.733.270.000 $ | 83.808.000 $ |
| 2023-09-30 | 10-Q | – | 81.837.000 $ | 0,61 $ | 1.892.662.000 $ | 249.181.000 $ |
| 2023-06-30 | 10-Q | – | 74.754.000 $ | 0,56 $ | 1.810.440.000 $ | 151.033.000 $ |
| 2023-03-31 | 10-Q | – | 39.615.000 $ | 0,29 $ | 1.699.447.000 $ | 65.850.000 $ |
| 2022-12-31 | 10-K | – | 202.129.000 $ | 1,44 $ | 1.841.511.000 $ | 169.798.000 $ |
| 2022-09-30 | 10-Q | – | 61.634.000 $ | 0,44 $ | 1.864.543.000 $ | 96.991.000 $ |
| 2022-06-30 | 10-Q | – | 22.685.000 $ | 0,16 $ | 1.781.390.000 $ | 293.171.000 $ |
| 2022-03-31 | 10-Q | – | 60.108.000 $ | 0,43 $ | 1.162.248.000 $ | 260.256.000 $ |
| 2021-12-31 | 10-K | – | 402.710.000 $ | 2,74 $ | 1.104.429.000 $ | 196.953.000 $ |
| 2021-09-30 | 10-Q | – | 216.587.000 $ | 1,48 $ | 1.185.420.000 $ | 281.674.000 $ |
| 2021-06-30 | 10-Q | – | 91.458.000 $ | 0,62 $ | 1.025.863.000 $ | 119.746.000 $ |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Royalty | 867,8 Mio. | 571,0 Mio. | 447,9 Mio. | 360,5 Mio. | 203,9 Mio. | 62,1 % | +52,0% | |
| Product | 376,4 Mio. | 303,5 Mio. | 300,9 Mio. | 191,0 Mio. | 104,2 Mio. | 27,0 % | +24,0% | |
| Proprietary Products Sales | 194,6 Mio. | 166,6 Mio. | 130,8 Mio. | 72,8 Mio. | – | 13,9 % | +16,8% | |
| Collaborative Agreements | 152,3 Mio. | 140,8 Mio. | 80,5 Mio. | 108,6 Mio. | 135,2 Mio. | 10,9 % | +8,2% | |
| Bulk RHu PH 20 | 133,0 Mio. | 86,3 Mio. | 115,4 Mio. | – | – | 9,5 % | +54,1% | |
| Salesbasedmilestone | 70,0 Mio. | 30,0 Mio. | – | 10,0 Mio. | 50,0 Mio. | 5,0 % | +133,3% | |
| Device Partnered Products | 48,8 Mio. | 50,5 Mio. | 54,6 Mio. | 36,1 Mio. | – | 3,5 % | -3,4% | |
| Event Based Development And Regulatory Milestone And Other Fees | 47,0 Mio. | 72,5 Mio. | 69,0 Mio. | – | – | 3,4 % | -35,2% | |
| Upfront Fees | 18,5 Mio. | 27,0 Mio. | – | – | – | 1,3 % | -31,6% | |
| Device Licensing And Development | 16,9 Mio. | 11,3 Mio. | – | – | – | 1,2 % | +48,6% | |
| Researchand Development Services | – | – | 9,5 Mio. | 9,6 Mio. | 1,2 Mio. | – | – | |
| Upfrontfees | – | – | 2,0 Mio. | 30,0 Mio. | 42,0 Mio. | – | – | |
| Bulkr Hu PH 20 | – | – | – | 82,1 Mio. | 81,0 Mio. | – | – | |
| Development Fees | – | – | – | 59,0 Mio. | 42,0 Mio. | – | – | |
| Hylenex Recombinant | – | – | – | – | 23,3 Mio. | – | – |
Quartalsverlauf
| Segment | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Royalty | 236,0 Mio. | 205,6 Mio. | 168,2 Mio. | 155,1 Mio. | 124,9 Mio. | 120,6 Mio. | 66,6 % | +52,2% | |
| Product | 94,2 Mio. | 81,5 Mio. | 78,0 Mio. | 86,7 Mio. | 78,9 Mio. | 58,6 Mio. | 26,6 % | +8,7% | |
| Proprietary Products Sales | 52,2 Mio. | 46,5 Mio. | 36,3 Mio. | 39,9 Mio. | 44,1 Mio. | 35,3 Mio. | 14,7 % | +30,9% | |
| Bulkr Hu PH 20 | 32,5 Mio. | 23,3 Mio. | 27,0 Mio. | 31,5 Mio. | 24,6 Mio. | 10,5 Mio. | 9,2 % | +3,2% | |
| Collaborative Agreements | 24,0 Mio. | 38,6 Mio. | 18,6 Mio. | 48,4 Mio. | 27,5 Mio. | 16,7 Mio. | 6,8 % | -50,4% | |
| Sales Based Milestone | 20,0 Mio. | 10,0 Mio. | 15,0 Mio. | – | – | – | 5,6 % | Neu | |
| Device Partnered Products | 9,5 Mio. | 11,8 Mio. | 14,7 Mio. | 15,2 Mio. | 10,1 Mio. | 12,8 Mio. | 2,7 % | -37,7% | |
| Device Licensing And Development | 4,0 Mio. | 4,1 Mio. | 3,4 Mio. | 3,4 Mio. | 2,0 Mio. | 2,7 Mio. | 1,1 % | +18,8% | |
| Event Based Development And Regulatory Milestone And Other Fees | – | 24,5 Mio. | – | 18,0 Mio. | 25,5 Mio. | 14,0 Mio. | – | – | |
| Upfrontfees | – | – | 220.000 | 27,0 Mio. | – | – | – | – |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 11.05.2026 | 376,7 Mio. USD | 1,22 |
| Q3 2025 | 30.09.2025 | 03.11.2025 | 354,3 Mio. USD | 1,43 |
| Q2 2025 | 30.06.2025 | 05.08.2025 | 325,7 Mio. USD | 1,33 |
| Q1 2025 | 31.03.2025 | 06.05.2025 | 264,9 Mio. USD | 0,93 |
| Q3 2024 | 30.09.2024 | 31.10.2024 | 290,1 Mio. USD | 1,05 |
| Q2 2024 | 30.06.2024 | 06.08.2024 | 231,4 Mio. USD | 0,72 |
| Q1 2024 | 31.03.2024 | 07.05.2024 | 195,9 Mio. USD | 0,60 |
| Q3 2023 | 30.09.2023 | 06.11.2023 | 216,0 Mio. USD | 0,61 |
| Q2 2023 | 30.06.2023 | 08.08.2023 | 221,0 Mio. USD | 0,56 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 11.05.2026 | 10-Q | 31.03.2026 | 41 Tage | SEC » |
| 17.02.2026 | 10-K | 31.12.2025 | 48 Tage | SEC » |
| 03.11.2025 | 10-Q | 30.09.2025 | 34 Tage | SEC » |
| 05.08.2025 | 10-Q | 30.06.2025 | 36 Tage | SEC » |
| 06.05.2025 | 10-Q | 31.03.2025 | 36 Tage | SEC » |
| 18.02.2025 | 10-K | 31.12.2024 | 49 Tage | SEC » |
| 31.10.2024 | 10-Q | 30.09.2024 | 31 Tage | SEC » |
| 06.08.2024 | 10-Q | 30.06.2024 | 37 Tage | SEC » |
| 07.05.2024 | 10-Q | 31.03.2024 | 37 Tage | SEC » |
| 20.02.2024 | 10-K | 31.12.2023 | 51 Tage | SEC » |
| 06.11.2023 | 10-Q | 30.09.2023 | 37 Tage | SEC » |
| 08.08.2023 | 10-Q | 30.06.2023 | 39 Tage | SEC » |
| 09.05.2023 | 10-Q | 31.03.2023 | 39 Tage | SEC » |
| 21.02.2023 | 10-K | 31.12.2022 | 52 Tage | SEC » |
| 08.11.2022 | 10-Q | 30.09.2022 | 39 Tage | SEC » |
| 09.08.2022 | 10-Q | 30.06.2022 | 40 Tage | SEC » |
| 10.05.2022 | 10-Q | 31.03.2022 | 40 Tage | SEC » |
| 22.02.2022 | 10-K | 31.12.2021 | 53 Tage | SEC » |
| 02.11.2021 | 10-Q | 30.09.2021 | 33 Tage | SEC » |
| 09.08.2021 | 10-Q | 30.06.2021 | 40 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 23.02.2021 | 10-K | 31.12.2020 | 54 Tage | SEC » |
| 02.11.2020 | 10-Q | 30.09.2020 | 33 Tage | SEC » |
| 10.08.2020 | 10-Q | 30.06.2020 | 41 Tage | SEC » |
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 23.03.2026 | HV-Einladung | — | — | DEFA14A | SEC » |
| 23.03.2026 | HV-Einladung | 05.05.2026 Jahres-HV | 09.03.2026 | DEF 14A | SEC » |
| 18.03.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 18.03.2025 | HV-Einladung | 01.05.2025 Jahres-HV | 04.03.2025 | DEF 14A | SEC » |
| 15.03.2024 | HV-Einladung | — | — | DEFA14A | SEC » |
| 15.03.2024 | HV-Einladung | 25.04.2024 Jahres-HV | 26.02.2024 | DEF 14A | SEC » |
| 04.03.2024 | Vorläufig | — | — | PRE 14A | SEC » |
| 24.03.2023 | HV-Einladung | — | — | DEFA14A | SEC » |
| 24.03.2023 | HV-Einladung | 05.05.2023 Jahres-HV | 06.03.2023 | DEF 14A | SEC » |
| 18.04.2022 | HV-Einladung | — | — | DEFA14A | SEC » |
| 25.03.2022 | HV-Einladung | — | — | DEFA14A | SEC » |
| 25.03.2022 | HV-Einladung | 05.05.2022 Jahres-HV | 07.03.2022 | DEF 14A | SEC » |
| 26.03.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 26.03.2021 | HV-Einladung | 05.05.2021 Jahres-HV | 08.03.2021 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
Übernahmen & Fusionen (M&A)
M&A-relevante SEC-Filings der letzten sechs Jahre: Übernahmeangebote (Tender Offers), Fusionen (425/S-4), Aktienrückkauf-Angebote (Self-Tender) und Going-Private-Transaktionen. Geführt nach dem einreichenden Emittenten.
| Datum (US) | Kategorie | Form | Deal-Konditionen | SEC |
|---|---|---|---|---|
| 24.05.2022 | Übernahmeangebot | SC TO-T/A | – | SEC » |
| 12.05.2022 | Übernahmeangebot | SC TO-T/A | – | SEC » |
| 02.05.2022 | Übernahmeangebot | SC TO-T/A | – | SEC » |
| 26.04.2022 | Übernahmeangebot | SC TO-T | $5,60 Cash | SEC » |
| 14.04.2022 | Übernahmeangebot | SC TO-C | – | SEC » |
| 13.04.2022 | Übernahmeangebot | SC TO-C | – | SEC » |
| 13.04.2022 | Übernahmeangebot | SC TO-C | – | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Deal-Konditionen aus dem Dokument extrahiert (Tender: SC TO-T/-I/SC 14D9; Fusion: 425/S-4 — Gegenpartei + Umtauschverhältnis), ohne Gewähr — Original siehe SEC-Link.
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (02.07.2026)
HOCH Abgang Schlüsselpersonen (02.07.2026)
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 02.07.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 30.04.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 09.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 08.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 24.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 03.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 06.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 21.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 13.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 23.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 06.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 15.03.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 13.12.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 24.02.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 02.07.2026 | Personalwechsel | -0,35 | 65 | Halozyme gab die Abreise von Cortney Caudill als Chief Operating Officer zum 30. Juni 2026 bekannt. Das Unternehmen dankte ihr für ihre Beit… 🔒 | SEC |
| 11.05.2026 | Quartalszahlen | 0,00 | 65 | HaloZyme meldete am 11. Mai 2026 Finanzergebnisse für Q1 2026. Der Pressemitteilung ist als Exhibit 99.1 beigefügt. | SEC |
| 07.05.2026 | HV-Abstimmung | 0,00 | 25 | HaloZyme hielt die Jahreshauptversammlung am 5. Mai 2026 mit einer Präsenzquote von 88,2% ab. Drei Anträge wurden zur Abstimmung gestellt. | SEC |
| 30.04.2026 | Personalwechsel | 0,30 | 50 | HaloZyme Therapeutics gab die Ernennung von Darren Snellgrove zum Chief Financial Officer bekannt, wirksam ab 8. Juni 2026. Snellgrove war z… 🔒 | SEC |
| 12.03.2026 | Personalwechsel | -0,10 | 65 | David Ramsay wurde mit Wirkung zum 23. März 2026 zum Interim Chief Financial Officer ernannt. Der 61-Jährige war seit April 2017 Vorstandsmi… 🔒 | SEC |
| 17.02.2026 | Quartalszahlen | 0,00 | 55 | Halozyme meldete Geschäftsergebnisse für das vierte Quartal 2025. Die Finanzergebnisse wurden in einer Pressemitteilung veröffentlicht. | SEC |
| 28.01.2026 | Quartalszahlen | 0,00 | 70 | Das Unternehmen veröffentlichte vorläufige Schätzungen der Finanzergebnisse für 2025 und die Finanzprognose für 2026. | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-07-09 | 750 | 80,37 | 60.278 |
| 2026-07-06 | 4.643 | 79,45 | 368.886 |
| 2026-06-29 | 24.256 | 74,96 | 1.818.230 |
| 2026-06-26 | 8.279 | 72,64 | 601.387 |
| 2026-06-25 | 3.517 | 71,15 | 250.235 |
| 2026-06-24 | 3.233 | 69,62 | 225.081 |
| 2026-06-18 | 6 | 68,57 | 411 |
| 2026-06-15 | 129 | 69,50 | 8.966 |
| 2026-06-10 | 47 | 71,48 | 3.360 |
| 2026-06-05 | 29.083 | 71,60 | 2.082.343 |
| 2026-05-26 | 1.046 | 68,32 | 71.463 |
| 2026-05-20 | 6 | 68,73 | 412 |
| 2026-05-19 | 16 | 67,44 | 1.079 |
| 2026-05-18 | 437 | 67,12 | 29.331 |
| 2026-05-13 | 662 | 70,93 | 46.956 |
| 2026-05-08 | 13 | 65,19 | 847 |
| 2026-05-04 | 1.646 | 63,96 | 105.278 |
| 2026-04-29 | 8.514 | 63,86 | 543.704 |
| 2026-04-28 | 950 | 64,49 | 61.265 |
| 2026-04-24 | 67 | 66,59 | 4.462 |
| 2026-04-23 | 215 | 68,40 | 14.706 |
| 2026-04-17 | 45 | 66,64 | 2.999 |
| 2026-04-16 | 36 | 68,05 | 2.450 |
| 2026-04-08 | 2.291 | 63,60 | 145.708 |
| 2026-04-02 | 1.226 | 65,40 | 80.180 |
| 2026-03-31 | 2 | 62,13 | 124 |
| 2026-03-27 | 2.106 | 63,29 | 133.289 |
| 2026-03-25 | 16 | 62,04 | 993 |
| 2026-03-24 | 628 | 62,86 | 39.476 |
| 2026-03-20 | 22 | 63,27 | 1.392 |
| 2026-03-18 | 52 | 65,13 | 3.387 |
| 2026-03-13 | 27.130 | 63,56 | 1.724.383 |
| 2026-03-12 | 59 | 66,48 | 3.922 |
| 2026-03-09 | 13.166 | 67,37 | 886.993 |
| 2026-02-26 | 147 | 70,35 | 10.341 |
| 2026-02-19 | 489 | 73,23 | 35.809 |
| 2026-02-11 | 5.611 | 80,22 | 450.114 |
| 2026-02-09 | 97 | 81,23 | 7.879 |
| 2026-02-05 | 2 | 77,93 | 156 |
| 2026-02-04 | 27.392 | 76,48 | 2.094.940 |
| 2026-02-03 | 3.111 | 74,45 | 231.614 |